ASX:SQ2 28 February 2026 - 1 March 2026

July 1, 2026, 7:47 PM EDT. IperionX Limited (ASX:IPX) landed as much as US$6.6 million from a U.S. Department of Defense program to boost titanium plate and parts production at its Virginia site. The funding stacks on top of previous prototype and purchase deals. IperionX is still pre-revenue and has logged net losses over US$30 million, with investors keeping an eye on the company's execution risks. Shares are valued between A$8.87 and A$10.51, as the market weighs the company's hefty spend and ongoing losses. The contract could validate IperionX's titanium process and scale, though investors remain cautious about future performance.